PATENT CLAIM ANALYSIS

Application Number: 15781839
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "158100"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of systemic sclerosis. In particular, the present invention relates to a method of treating systemic sclerosis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of vanin-1 inhibitor.

Claim (Index 3):
A method of determining the severity of systemic sclerosis in a subject comprising i) determining the level of vanin-1 activity in a blood sample obtained from the subject ii) comparing the level determined at step i) with a predetermined reference value and iii) concluding that the subject suffers from a severe form of systemic sclerosis when the level determined at step i) is higher than the predetermined reference value or concluding that the subject suffers from limited form of systemic sclerosis.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 94.0
- Lexical Diversity: 1.48485
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14390562', '14471968', '13138608', '15627755', '14642546']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6444352200656636
- 35 USC 102 Novelty (BERT): 0.4929614972720028
- Combined Prediction Score: 0.6292878477862975
- Mean Citation Score: 144.52459800000003
- Max Citation Score: 150.77945
- Similarity Product: 96.47198323512376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test